LEADER 00672cam1 2200241 450 001 E600200008097 005 20170221135524.0 100 $a20041130d1956 |||||ita|0103 ba 101 $aita 102 $aIT 200 1 $aLeonardo da Vinci 210 $aNovara$cIstituto geografico De Agostini$d1956 215 $a2 v.$cill.$d38 cm 300 $aIn custodia 463 1$1001SOBE00054755$12000 $a1 463 1$1001SOBE00054756$12000 $a2 702 0$aLeonardo : da Vinci$3A600200057692$4070 801 0$aIT$bUNISOB$c20170221$gRICA 912 $aE600200008097 940 $aM 102 Monografia moderna SBN 941 $aM 996 $aLeonardo da Vinci$9116841 997 $aUNISOB LEADER 05183nam 2200733 450 001 9910132463603321 005 20230803201547.0 010 $a1-118-63508-6 010 $a1-118-63506-X 010 $a1-118-63505-1 035 $a(CKB)3580000000001159 035 $a(EBL)1674214 035 $a(SSID)ssj0001181629 035 $a(PQKBManifestationID)11786988 035 $a(PQKBTitleCode)TC0001181629 035 $a(PQKBWorkID)11145025 035 $a(PQKB)10612133 035 $a(OCoLC)891387064 035 $a(MiAaPQ)EBC1674214 035 $a(DLC) 2013046554 035 $a(Au-PeEL)EBL1674214 035 $a(CaPaEBR)ebr10925531 035 $a(CaONFJC)MIL601770 035 $a(OCoLC)878262968 035 $a(EXLCZ)993580000000001159 100 $a20140912h20142014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aMilk and dairy products as functional foods /$fedited by Ara Kanekanian 210 1$aChichester, England :$cWiley-Blackwell,$d2014. 210 4$dİ2014 215 $a1 online resource (406 p.) 225 1 $aSociety of Dairy Technology series 300 $aDescription based upon print version of record. 311 $a1-4443-3683-5 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aCover; Title Page; Copyright; Contents; Preface to the Technical Series; Preface; List of Contributors; Chapter 1 The Health Benefits of Bioactive Compounds from Milk and Dairy Products; 1.1 The importance of milk and dairy products; 1.2 Dairy products: Concerns and challenges; 1.3 Dairy products and public health; 1.3.1 Heart disease; 1.4 Major nutrients in milk; 1.4.1 Proteins; 1.4.2 Milk fat; 1.4.3 Lactose and its derivatives; 1.4.4 Vitamins and minerals; 1.5 Dairy products as functional foods; 1.6 Bioactive compounds from milk; 1.6.1 Bioactive peptides; 1.6.2 Other bioactivities 327 $a1.7 Probiotics and dairy products1.8 Summary and future trends; References; Chapter 2 Bioactive Peptides from Casein and Whey Proteins; 2.1 Introduction; 2.2 Direct effects of casein and whey peptides on host immunity; 2.2.1 Immunomodulatory peptides derived from casein; 2.2.2 Immunomodulatory peptides derived from whey proteins; 2.2.3 Indirect effects of casein and whey peptides on host immunity; 2.3 Antimicrobial peptides; 2.3.1 Antimicrobial peptides derived from casein; 2.3.2 Antimicrobial peptides derived from whey proteins; 2.4 Peptides that stimulate the gut microbiota 327 $a2.5 Peptides that regulate gut homeostasis2.6 Potential for peptide bioactivities in vivo and outlook for the future; References; Chapter 3 Colostrum: Its Health Benefits; 3.1 Introduction; 3.2 Bioactive constituents of colostrums; 3.2.1 Peptide growth factors; 3.2.2 Non-peptide growth factors; 3.2.3 Immunological factors; 3.3 Bovine colostrum use in human health; 3.3.1 Gastrointestinal diseases; 3.3.2 Non-gastrointestinal diseases; 3.3.3 Colostrum and athletic performance; 3.4 Considerations; 3.5 Conclusion; References; Chapter 4 Casein and Whey Proteins in Human Health; 4.1 Introduction 327 $a4.2 Casein-derived proteins and their effect in human health4.2.1 The cardiovascular system; 4.2.2 The nervous system; 4.2.3 The immune system; 4.2.4 The nutrition system; 4.3 Whey proteins and their direct and indirect effects on human health; 4.3.1 ?-lactoglobulin; 4.3.2 ?-lactalbumin; 4.3.3 Immunoglobulins; 4.3.4 Bovine serum albumin; 4.3.5 Lactoferrin; 4.3.6 Lysozyme; 4.3.7 Lactoperoxidase; 4.3.8 Casein macropeptides; 4.3.9 Other enzymes contained in the whey; 4.4 The effect of processing on the bioactivity of casein and whey proteins; 4.4.1 The effect of heat treatment 327 $a4.4.2 The effect of ultra-high-pressure processing4.4.3 The effect of protein hydrolysation; 4.4.4 The role of processing in the production of allergenic or bitter-tasting peptides; 4.5 Bioactive peptides production from milk and whey proteins; 4.5.1 Enzymatic hydrolysis; 4.5.2 Microbial fermentation; 4.5.3 Proteolysis; 4.6 Fractionation and enrichment of bioactive peptides; 4.7 Commercial applications and future outlook; 4.8 Conclusion; References; Chapter 5 Sports Nutrition and Dairy Products; 5.1 Introduction; 5.2 Energy balance; 5.3 Carbohydrates 327 $a5.3.1 Total dietary carbohydrate requirement 330 $a"This book draws together a wealth of information regarding the functional health benefits of milk and dairy products"--$cProvided by publisher. 410 0$aSociety of Dairy Technology series 606 $aDairy products in human nutrition 606 $aMilk$xAnalysis 606 $aFunctional foods 615 0$aDairy products in human nutrition. 615 0$aMilk$xAnalysis. 615 0$aFunctional foods. 676 $a613.2/6 686 $aTEC012000$2bisacsh 702 $aKanekanian$b A$g(Ara), 712 02$aSociety of Dairy Technology. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910132463603321 996 $aMilk and dairy products as functional foods$91913823 997 $aUNINA LEADER 02457nam 2200553 a 450 001 9910781348703321 005 20230725051937.0 010 $a1-59332-550-9 035 $a(CKB)2550000000035436 035 $a(EBL)837744 035 $a(OCoLC)732955761 035 $a(SSID)ssj0000553389 035 $a(PQKBManifestationID)11343845 035 $a(PQKBTitleCode)TC0000553389 035 $a(PQKBWorkID)10505119 035 $a(PQKB)11717249 035 $a(MiAaPQ)EBC837744 035 $a(Au-PeEL)EBL837744 035 $a(CaPaEBR)ebr10430429 035 $a(EXLCZ)992550000000035436 100 $a20100115d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aForensic rhetoric$b[electronic resource] $ethe force of closing arguments /$fSusanna Shelton Clason 210 $aEl Paso, Tex. $cLFB Scholarly Pub.$d2010 215 $a1 online resource (169 p.) 225 1 $aCriminal justice : recent scholarship 300 $aDescription based upon print version of record. 311 $a1-59332-383-2 320 $aIncludes bibliographical references (p. 139-154) and index. 327 $aThe power of legal rhetoric -- Research design and analytic strategy -- Ethos : a rhetoric of impression -- Logos : the rhetoric of reasoning -- Pathos : a rhetoric of engagement -- Conclusions. 330 $aClason focuses on the closing argument rhetorical practices of five trial attorneys. She seeks to 1) learn how participants utilized rhetorical strategies in closing argument; 2) better understand how they selected those strategies; and 3) examine why they employed the strategies they did through the central categories of ethos, logos, and pathos. Study participants' awareness and consideration of the classical speaker, audience, and message Aristotelian speech situation as well as the power of persuasion demonstrates the continued influence of rhetoric in courts and rhetorical nature of legal 410 0$aCriminal justice (LFB Scholarly Publishing LLC) 606 $aSummation (Law)$zUnited States 606 $aForensic oratory 615 0$aSummation (Law) 615 0$aForensic oratory. 676 $a347.73/75 700 $aClason$b Susanna Shelton$01503424 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910781348703321 996 $aForensic rhetoric$93731796 997 $aUNINA